Roger S. Chung

7.5k total citations · 1 hit paper
141 papers, 5.5k citations indexed

About

Roger S. Chung is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Roger S. Chung has authored 141 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 43 papers in Neurology and 32 papers in Cellular and Molecular Neuroscience. Recurrent topics in Roger S. Chung's work include Amyotrophic Lateral Sclerosis Research (31 papers), Trace Elements in Health (30 papers) and Alzheimer's disease research and treatments (22 papers). Roger S. Chung is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (31 papers), Trace Elements in Health (30 papers) and Alzheimer's disease research and treatments (22 papers). Roger S. Chung collaborates with scholars based in Australia, China and United States. Roger S. Chung's co-authors include Adrian K. West, James C. Vickers, Bingyang Shi, Marco Morsch, Rowan A. W. Radford, Albert Lee, Meng Zheng, Dean L. Pountney, Gilles J. Guillemin and Meng Inn Chuah and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Roger S. Chung

139 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Microglia morphophysiological diversity and its implications for the CNS

2022 190 citations Andrés Vidal-Itriago, Rowan A. W. Radford et al. profile →

Peers

Countries citing papers authored by Roger S. Chung

Since Specialization

Citations

This map shows the geographic impact of Roger S. Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger S. Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger S. Chung more than expected).

Fields of papers citing papers by Roger S. Chung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger S. Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger S. Chung. The network helps show where Roger S. Chung may publish in the future.

Co-authorship network of co-authors of Roger S. Chung

This figure shows the co-authorship network connecting the top 25 collaborators of Roger S. Chung. A scholar is included among the top collaborators of Roger S. Chung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger S. Chung. Roger S. Chung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Proteomics Analysis of the TDP ‐43 Interactome in Cellular Models of ALS Pathogenesis 2025 ·Journal of Neurochemistry ·(unknown), (unknown), (unknown), Jennilee M. Davidson, (unknown), Lívia Rosa-Fernandes, Rebecca San Gil, (unknown), (unknown), (unknown), (unknown), Roger S. Chung, Adam K. Walker, Stephanie L. Rayner, Marco Morsch, Albert Lee	1
2	ALS-linked CCNF variant disrupts motor neuron ubiquitin homeostasis 2023 ·Human Molecular Genetics ·Natalie E. Farrawell, (unknown), Luke McAlary, (unknown), (unknown), Dzung Do‐Ha, Stephanie L. Rayner, Ian P. Blair, Roger S. Chung, Justin J. Yerbury, Lezanne Ooi, Darren N. Saunders	4
3	Aspect Ratio of PEGylated Upconversion Nanocrystals Affects the Cellular Uptake In Vitro and In Vivo 2022 ·Acta Biomaterialia ·Libing Fu, Bingyang Shi, Shihui Wen, Marco Morsch, Guoying Wang, Zhiguang Zhou, Chao Mi, Mohammad Sadraeian, Gungun Lin, Yiqing Lu, Dayong Jin, Roger S. Chung	19
4	Sodium valproate increases activity of the sirtuin pathway resulting in beneficial effects for spinocerebellar ataxia-3 in vivo 2021 ·Molecular Brain ·Maxinne Watchon, Luan Luu, Katherine J. Robinson, Kristy C. Yuan, (unknown), (unknown), (unknown), Gilles J. Guillemin, Nicholas J. Cole, Garth A. Nicholson, Roger S. Chung, Albert Lee, Angela S. Laird	14
5	Riluzole does not ameliorate disease caused by cytoplasmic TDP‐43 in a mouse model of amyotrophic lateral sclerosis 2021 ·European Journal of Neuroscience ·Amanda L. Wright, Paul A. Della Gatta, Sheng Le, Britt A. Berning, Prachi Mehta, Kelly R. Jacobs, (unknown), Rebecca San Gil, (unknown), (unknown), (unknown), (unknown), (unknown), Roger S. Chung, Julie D. Atkin, Albert Lee, Bingyang Shi, Catherine A. Blizzard, Marco Morsch, Adam K. Walker	16
6	In vivo Validation of Bimolecular Fluorescence Complementation (BiFC) to Investigate Aggregate Formation in Amyotrophic Lateral Sclerosis (ALS) 2021 ·Molecular Neurobiology ·Emily K. Don, (unknown), Rowan A. W. Radford, Natalie M. Scherer, Andrés Vidal-Itriago, Alison Hogan, Cindy Maurel, (unknown), (unknown), Thomas E. Hall, Albert Lee, Bingyang Shi, Nicholas J. Cole, Angela S. Laird, Andrew P. Badrock, Roger S. Chung, Marco Morsch	9
7	Correction: SERS-based nanostrategy for rapid anemia diagnosis 2021 ·Nanoscale ·Pir Muhammad, Sumaira Hanif, (unknown), Fawad Ur Rehman, Jiefei Wang, Maqbool Khan, Roger S. Chung, Albert Lee, Meng Zheng, Yuling Wang, Bingyang Shi	2
8	Advances in nanotechnology-based strategies for the treatments of amyotrophic lateral sclerosis 2020 ·Materials Today Bio ·Guoying Wang, Stephanie L. Rayner, Roger S. Chung, Bingyang Shi, (unknown)	49
9	Charge Conversional Biomimetic Nanocomplexes as a Multifunctional Platform for Boosting Orthotopic Glioblastoma RNAi Therapy 2020 ·Nano Letters ·Yanjie Liu, Yan Zou, Chan Feng, Albert Lee, Jinlong Yin, Roger S. Chung, (unknown), Helen Rizos, Wei Tao, Meng Zheng, Omid C. Farokhzad, Bingyang Shi	145
10	The influence of metallothionein treatment and treadmill running exercise on disease onset and survival in SOD1 ^G93A amyotrophic lateral sclerosis mice 2020 ·European Journal of Neuroscience ·Katherine E. Lewis, William M. Bennett, Christopher Leigh Blizzard, Adrian K. West, Roger S. Chung, Meng Inn Chuah	2
11	Isotope metallomics approaches for medical research 2020 ·Cellular and Molecular Life Sciences ·Brandon Mahan, Roger S. Chung, Dean L. Pountney, Frédéric Moynier, Simon Turner	26
12	Using proteomics to identify ubiquitin ligase–substrate pairs: how novel methods may unveil therapeutic targets for neurodegenerative diseases 2019 ·Cellular and Molecular Life Sciences ·Stephanie L. Rayner, Marco Morsch, Mark P. Molloy, Bingyang Shi, Roger S. Chung, Albert Lee	17
13	SERS-based nanostrategy for rapid anemia diagnosis 2019 ·Nanoscale ·Pir Muhammad, Sumaira Hanif, (unknown), Fawad Ur Rehman, Jiefei Wang, Maqbool Khan, Roger S. Chung, Albert Lee, Meng Zheng, Yuling Wang, Bingyang Shi	17
14	DNA nanoclew templated spherical nucleic acids for siRNA delivery 2018 ·Chemical Communications ·Weimin Ruan, Meng Zheng, (unknown), Yuanyuan Liu, David B. Lovejoy, (unknown), Yan Zou, Albert Lee, Shu Yang, Yiqing Lu, Marco Morsch, Roger S. Chung, Bingyang Shi	52
15	Challenges in DNA Delivery and Recent Advances in Multifunctional Polymeric DNA Delivery Systems 2017 ·Biomacromolecules ·Bingyang Shi, Meng Zheng, Wei Tao, Roger S. Chung, Dayong Jin, (unknown), Omid C. Farokhzad	166
16	A versatile upconversion surface evaluation platform for bio–nano surface selection for the nervous system 2017 ·Nanoscale ·Libing Fu, Marco Morsch, Bingyang Shi, Guoying Wang, Albert Lee, Rowan A. W. Radford, Yiqing Lu, Dayong Jin, Roger S. Chung	15
17	A Tol2 Gateway-Compatible Toolbox for the Study of the Nervous System and Neurodegenerative Disease 2016 ·Zebrafish ·Emily K. Don, (unknown), Andrew P. Badrock, Thomas E. Hall, Marco Morsch, Elinor Hortle, Alison Hogan, Sharron Chow, (unknown), (unknown), Garth A. Nicholson, Roger S. Chung, Nicholas J. Cole	45
18	SOD1 Pathology in ALS: TDP or not TDP that is the Question 2016 ·(unknown), Rowan A. W. Radford, (unknown), Marco Morsch, Roger S. Chung, (unknown)	1
19	Amyloid β accumulation and inner retinal degenerative changes in Alzheimer’s disease transgenic mouse 2016 ·Neuroscience Letters ·Vivek Gupta, Nitin Chitranshi, Veer Bala Gupta, Mojtaba Golzan, Yogita Dheer, Roshana Vander Wall, Dana Georgevsky, Anna E. King, James C. Vickers, Roger S. Chung, Stuart L. Graham	95
20	Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase 2014 ·Journal of Neuroinflammation ·Katherine E. Lewis, (unknown), William Bennett, Anna E. King, Adrian K. West, Roger S. Chung, Meng Inn Chuah	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact